Trial of Pindolol Augmentation in Venlafaxine Treated Patients With Major Depression
Status:
Terminated
Trial end date:
2007-09-01
Target enrollment:
Participant gender:
Summary
This study investigates the hypothesis that pindolol can accelerate the response to
antidepressants in patients with major depression treated with venlafaxine.
Phase:
N/A
Details
Lead Sponsor:
Hillerod Hospital, Denmark
Collaborators:
Tvergaards Foundation Wyeth is now a wholly owned subsidiary of Pfizer